Michael Paul, Ph.D., CEO of Lineagen, Inc., Nominated for Prestigious Entrepreneur of the Year Award

May 14, 2018

EY (Ernst & Young) Award recognizes entrepreneurs “…whose boldness drives them to do things differently and change our world in the most unexpected ways.”

Read more

Lineagen, Inc. Named to MountainWest Capital Network's 2017 Utah 100

November 8, 2017

Lineagen was named to the 2017 Utah 100, MountainWest Capital Network’s (MWCN) annual list of the fastest-growing companies in Utah.

Read more

Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis for Childhood Developmental Delay

October 19, 2016

Lineagen, Inc. announced today the presentation at annual meeting of the American Society of Human Genetics (ASHG) and commercial launch of a Proprietary Variant Index
 

Read more

Lineagen Announces Identification of New Genetic Region Associated with Seizures in Wolf-Hirschhorn Syndrome

January 12, 2016

Lineagen, Inc. announced today the publication of a major study revealing a significant genetic contributor to epilepsy in Wolf Hirschhorn syndrome.

Read more